Charles J. Hannan

High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

Karl E. Friedl, Charles J. Hannan, Robert E. Jones et al. · Metabolism · 1990 · 156 citations

Metabolic Syndrome, Lipid Disorder, Aromatizable Androgen +10

The Administration of Pharmacological Doses of Testosterone or 19-Nortestosterone to Normal Men is Not Associated with Increased Insulin Secretion or Impaired Glucose Tolerance*

Karl E. Friedl, Robert E. Jones, Charles J. Hannan et al. · The Journal of Clinical Endocrinology & Metabolism · 1989 · 81 citations

Comparison of the effects of high dose testosterone and 19-nortestosterone to a replacement dose of testosterone on strength and body composition in normal men

Karl E. Friedl, Joseph R. Dettori, Charles J. Hannan et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1991 · 68 citations

Body Composition, Replacement Dose, Exercise Physiology +6

Plasma atropine concentrations via intravenous, endotracheal, and intraosseous administration

Mark R. Prete, Charles J. Hannan, Frederick M Burkle · The American Journal of Emergency Medicine · 1987 · 43 citations

Plasma Atropine Concentrations, Medicine, Pharmacotherapy +5

Effects of high-intensity cycle exercise on sympathoadrenal-medullary response patterns

William J. Kraemer, John F. Patton, Howard G. Knuttgen et al. · Journal of Applied Physiology · 1991 · 30 citations

Sport Physiology, Physical Activity, Kinesiology +15